Kachru N, Carnahan RM, Johnson ML, et al. Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study. Drugs Aging 2015;32:379-89.
Ness J, Hoth A, Barnett MJ, et al. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother 2006;4:42-51.
Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC geriatrics 2015;15:31.
Uusvaara J, Pitkala KH, Kautiainen H, et al. Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study. Drugs & aging 2013;30:177-82.
Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis. British journal of clinical pharmacology 2015;80:209-20.
Huang, K. H., Chan, Y. F., Shih, H. C., & Lee, C. Y. (2012). 台灣老年人抗膽鹼潛在不適當用藥與不良結果之相關性研究. 藥物食品分析, 20(4), 930-937+985. https://doi.org/10.6227/jfda.2012200423